Is breast cancer HER2-positive curable?
- 1 people answered
Edit Tags
Tags are used to find the best answers
You might also be interested in
A new treatment for breast cancer has completely eradicated tumours in just 11 days. A team of researchers in the UK claims the new two-pronged technique could spare thousands of women from gruelling chemotherapy. Doctors combined two existing cancer drugs - Tyverb and Herceptin – and gave them t....
You can get in touch with the following associations for financial help. Cancer Patients Aid Association King George V. Memorial, Smt. Panadevi Dalmia Cancer, Management Centre, Dr. E. Moses Road, Mahalaxmi, Mumbai 400 011, Maharashtra, India. Telephone: +91 22 24924000 or +91 22 24928775 ....
Only decades ago doctors and health professionals used to warn about the negative effects of having too much coffee because of the risk that caffeine was believed to have on your body. However, the last decade has shed so much light on the health benefits of coffee and its relationship with can....
Credihealth is not a medical practitioner and does not provide medical advice. You should consult your doctor or with a healthcare professional before starting any diet, exercise, supplementation or medication program. Know More
लेखक:Dr. Nitika Sharma - BDS
समीक्षा की गई:Dr. Rakesh Kumar - MBBS, MS
Kanishka Pandey
HER2 is a gene that creates HER2 proteins or receptors. These receptors help control growth and repair of breast cells. An overexpression of HER2 protein causes out-of-control reproduction of breast cells.
HER2-positive breast cancers are known to be more aggressive than HER2-negative breast cancers and are more likely to recur than HER2-negative breast cancer. The recurrence usually takes place within five years of treatment.
The good news is that recurrence is less likely these days than ever before. This is largely due to the latest targeted treatments. In fact, most people treated for early stage HER2-positive breast cancer don’t relapse. If your breast cancer is HR-positive, hormonal therapy may help reduce the risk of recurrence.
Your treatment plan will probably include a combination of therapies such as:
Targeted treatments (medicines like Herceptin, Kadcyla, Perjeta and Tykerb are used in this process) Once the treatment ends, you’ll still need periodic testing for signs of recurrence.